{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:46:18Z","timestamp":1790837178189,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.antiviral.2016.06.011","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T08:55:36Z","timestamp":1467536136000},"page":"233-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever"],"prefix":"10.1016","volume":"132","author":[{"given":"Esragul","family":"Akinci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hurrem","family":"Bodur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Sunbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Leblebicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.06.011_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/vbz.2012.1061","article-title":"Pathogenesis of Crimean-Congo hemorrhagic fever","volume":"13","author":"Ak\u0131nc\u0131","year":"2013","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ijid.2013.06.005","article-title":"The relationship between the human leukocyte antigen system and Crimean-Congo hemorrhagic fever in the Turkish population","volume":"17","author":"Ak\u0131nc\u0131","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ijid.2008.08.027","article-title":"Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever","volume":"13","author":"Akinci","year":"2009","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000442177","article-title":"Serum \u03b2 defens\u0131n-2 levels and their relationship with clinical course and prognosis in patients with crimean-congo hemorrhagic fever","volume":"25","author":"Aksoy","year":"2016","journal-title":"Med. Princ. Pract."},{"issue":"5","key":"10.1016\/j.antiviral.2016.06.011_bib5","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4269\/ajtmh.1982.31.1066","article-title":"Serological evidence of human infection with Congo-Crimean hemorrhagic fever virus in Greece","volume":"31","author":"Antoniadis","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.06.011_bib6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/jmv.24174","article-title":"Toll-like receptor 7 Gln11Leu, c.4-151A\/G, and\u00a0+1817G\/T polymorphisms in Crimean Congo hemorrhagic fever","volume":"87","author":"Arslan","year":"2015","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/00365548.2011.623313","article-title":"Relationship between NF-\u03baB1 and NF-\u03baBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever","volume":"44","author":"Arslan","year":"2012","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jac\/dkr136","article-title":"Ribavirin for patients with Crimean- Congo haemorrhagic fever: a systematic review and meta-analysis","volume":"66","author":"Ascioglu","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"7","key":"10.1016\/j.antiviral.2016.06.011_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/jmv.24446","article-title":"Relationship of plasma cell-free DNA level with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever","volume":"88","author":"Bakir","year":"2016","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10096-014-2238-0","article-title":"Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF)","volume":"34","author":"Bak\u0131r","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib11","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/jmv.23666","article-title":"Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever","volume":"85","author":"Bakir","year":"2013","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/0972-9062.213375","article-title":"A\u00a0new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever","volume":"49","author":"Bakir","year":"2012","journal-title":"J.\u00a0Vector Borne Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1099\/jmm.0.45865-0","article-title":"Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures","volume":"54","author":"Bakir","year":"2005","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib14","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.ijid.2009.03.009","article-title":"Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?","volume":"14","author":"Barut","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7883\/yoken.JJID.2014.566","article-title":"Prognostic factors in Crimean-Congo hemorrhagic fever and the effect of leukocyte counts on mortality","volume":"69","author":"Bastug","year":"2016","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antivir. Res."},{"issue":"21","key":"10.1016\/j.antiviral.2016.06.011_bib17","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"Bente","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib18","first-page":"640","article-title":"Subclinical infections with Crimean-Congo hemorrhagic fever virus","volume":"18","author":"Bodur","year":"2012","journal-title":"Turk. Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib19","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.ijid.2010.09.009","article-title":"Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever","volume":"15","author":"Bodur","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib20","doi-asserted-by":"crossref","first-page":"e704","DOI":"10.1016\/j.ijid.2010.02.2240","article-title":"Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever","volume":"14","author":"Bodur","year":"2010","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2016.06.011_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/20477724.2015.1136130","article-title":"Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system","volume":"110","author":"Bozkurt","year":"2016","journal-title":"Pathog. Glob. Health"},{"issue":"9","key":"10.1016\/j.antiviral.2016.06.011_bib22","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1017\/S0950268808001878","article-title":"Genetic relationship in southern African Crimean-Congo haemorrhagic fever virus isolates: evidence for occurrence of reassortment","volume":"137","author":"Burt","year":"2009","journal-title":"Epidemiol. Infect."},{"issue":"4","key":"10.1016\/j.antiviral.2016.06.011_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1017\/S0950268805003730","article-title":"Molecular epidemiology of African and Asian Crimean-Congo haemorrhagic fever isolates","volume":"133","author":"Burt","year":"2005","journal-title":"Epidemiol. Infect."},{"issue":"8","key":"10.1016\/j.antiviral.2016.06.011_bib24","first-page":"839","article-title":"Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis","volume":"121","author":"Burt","year":"1997","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.antiviral.2016.06.011_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1590\/S1807-59322010000700008","article-title":"Determination of serum adenosine deaminase and xanthine oxidase levels in patients with crimean-congo hemorrhagic fever","volume":"65","author":"Celik","year":"2010","journal-title":"Clin. (Sao Paulo)"},{"key":"10.1016\/j.antiviral.2016.06.011_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijid.2007.09.010","article-title":"Clinical and laboratory features of Crimean- Congo hemorrhagic fever: predictors of fatality","volume":"12","author":"Cevik","year":"2008","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib27","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/521244","article-title":"Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever","volume":"45","author":"Cevik","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib28","doi-asserted-by":"crossref","first-page":"e799","DOI":"10.1016\/j.ijid.2013.02.030","article-title":"Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience","volume":"17","author":"Ceylan","year":"2013","journal-title":"Int. J. Infect. Dis."},{"issue":"15","key":"10.1016\/j.antiviral.2016.06.011_bib29","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1128\/JVI.02469-10","article-title":"Crimean-Congo hemorrhagic fever virus activates endothelial cells","volume":"85","author":"Connolly-Andersen","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib30","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/JVI.02070-06","article-title":"Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells","volume":"81","author":"Connolly-Andersen","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib31","doi-asserted-by":"crossref","DOI":"10.7883\/yoken.JJID.2015.392","article-title":"Presepsin levels of patients with Crimean-Congo Hemorrhagic fever","author":"Demirpen\u00e7e","year":"2016","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib32","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1128\/JVI.00752-06","article-title":"Crimean-Congo haemorrhagic fever virus genomics and global diversity","volume":"80","author":"Deyde","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cit527","article-title":"Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality","volume":"57","author":"Dokuzoguz","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib34","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3201\/eid1311.070222","article-title":"Viral load as predictor of Crimean-Congo hemorrhagic fever outcome","volume":"13","author":"Duh","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/vbz.2011.0694","article-title":"Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?","volume":"12","author":"Duygu","year":"2012","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/1076029612440035","article-title":"Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever","volume":"19","author":"Ekiz","year":"2013","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.antiviral.2016.06.011_bib37","article-title":"The relationship between IFNA1, IFNA5, IFNA10 and IFNA17 gene polymorphisms and Crimean-Congo Hemorrhagic Fever prognosis in a Turkish population range","author":"Elaldi","year":"2015","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jinf.2009.01.014","article-title":"Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey","volume":"58","author":"Elaldi","year":"2009","journal-title":"J.\u00a0Infect."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.antiviral.2016.06.011_bib39","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/j.ijid.2009.07.017","article-title":"A\u00a0newly identified Crimean-Congo hemorrhagic fever virus strain in Turkey","volume":"14","author":"Elevli","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/vbz.2009.0060","article-title":"Serum levels of Mannan-binding lectin in patients with Crimean-Congo hemorrhagic fever","volume":"10","author":"Engin","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.micinf.2010.07.012","article-title":"Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever","volume":"12","author":"Engin","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2016.06.011_bib42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1469-0691.2006.01445.x","article-title":"Analysis of risk factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited","volume":"2","author":"Ergonul","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2016.06.011_bib43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1086\/500836","article-title":"Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever","volume":"193","author":"Ergonul","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1086\/422000","article-title":"Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy","volume":"39","author":"Erg\u00f6n\u00fcl","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib45","doi-asserted-by":"crossref","first-page":"374010","DOI":"10.1155\/2015\/374010","article-title":"Clinical significance of neutrophil gelatinase-associated lipocalin in Crimean-Congo hemorrhagic Fever","volume":"2015","author":"Erturk","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.antiviral.2016.06.011_bib46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7883\/yoken.JJID.2014.485","article-title":"Procalcitonin level and its predictive effect on mortality in Crimean-Congo hemorrhagic fever patients","volume":"68","author":"Gul","year":"2015","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib47","doi-asserted-by":"crossref","first-page":"e26514","DOI":"10.5812\/jjm.26514","article-title":"Evaluation of prognostic values of tissue plasminogen activator and plasminogen activator inhibitor-1 in crimean-congo hemorrhagic fever patients","volume":"8","author":"Gurbuz","year":"2015","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcv.2015.12.006","article-title":"Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: viral load","volume":"75","author":"Hasanoglu","year":"2016","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib49","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/00365540903582418","article-title":"Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey","volume":"42","author":"Hatipoglu","year":"2010","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/1471-2334-14-416","article-title":"Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-\u03b1, IL-6, IL-10, and IFN-\u03b3levels in patients with Crimean-Congo hemorrhagic fever","volume":"14","author":"Kaya","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3906\/sag-1408-89","article-title":"Does the course of laboratory parameters help us to predict the outcome of CCHF?","volume":"46","author":"Kazanc\u0131o\u011flu","year":"2016","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.antiviral.2016.06.011_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcv.2009.11.007","article-title":"The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey","volume":"47","author":"Koksal","year":"2010","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib53","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1515\/CCLM.2009.347","article-title":"Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever","volume":"47","author":"Kurt","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.antiviral.2016.06.011_bib54","article-title":"Crimean-Congo Hemorrhagic Fever: a neglected infectious diseases with potential nosocomial infection threat","author":"Leblebicioglu","year":"2016","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.antiviral.2016.06.011_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2015.12.003","article-title":"Crimean-Congo hemorrhagic fever in Turkey: current status and future challenges","volume":"126","author":"Leblebicioglu","year":"2016","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.antiviral.2016.06.011_bib56","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jinf.2016.01.009","article-title":"Discharge criteria for Crimean-Congo haemorrhagic fever in endemic areas","volume":"72","author":"Leblebicioglu","year":"2016","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.antiviral.2016.06.011_bib57","unstructured":"Leblebicioglu H., Crimean-Congo Hemorrhagic Fever. In: UpToDate, Hirsch MS (Ed), UpToDate, Waltham, MA. (Accessed on May 29, 2016.)."},{"key":"10.1016\/j.antiviral.2016.06.011_bib58","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/vbz.2011.0896","article-title":"Case management and supportive treatment for patients with crimean-congo hemorrhagic fever","volume":"12","author":"Leblebicioglu","year":"2012","journal-title":"Vector Borne Zoonotic Dis."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2016.06.011_bib59","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.ijantimicag.2010.06.020","article-title":"Crimean-Congo haemorrhagic fever in Eurasia","volume":"36","author":"Leblebicioglu","year":"2010","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.antiviral.2016.06.011_bib60","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/375058","article-title":"The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran","volume":"36","author":"Mardani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib61","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/jmv.23521","article-title":"Diagnostic and prognostic value of Ischemia-modified albumin in patients with Crimean-Congo hemorrhagic fever","volume":"85","author":"Mentese","year":"2013","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib62","doi-asserted-by":"crossref","first-page":"e1042","DOI":"10.1016\/j.ijid.2013.03.014","article-title":"The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever","volume":"17","author":"Mentese","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5152\/eajm.2013.22","article-title":"Can serum ferritin level predict disease severity in patients with crimean-congo hemorrhagic Fever?","volume":"45","author":"Metanat","year":"2013","journal-title":"Eurasian J. Med."},{"issue":"9","key":"10.1016\/j.antiviral.2016.06.011_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-9-90","article-title":"The first clinical case due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus and a field survey","volume":"10","author":"Midilli","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jcla.20383","article-title":"Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality","volume":"24","author":"Onguru","year":"2010","journal-title":"J.\u00a0Clin. Lab. Anal."},{"key":"10.1016\/j.antiviral.2016.06.011_bib66","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jinf.2008.03.006","article-title":"High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality","volume":"56","author":"Onguru","year":"2008","journal-title":"J.\u00a0Infect."},{"issue":"1","key":"10.1016\/j.antiviral.2016.06.011_bib67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virusres.2009.12.014","article-title":"Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Turkey: occurrence of local topotype","volume":"149","author":"Ozkaya","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.06.011_bib68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5152\/eajm.2011.19","article-title":"Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever","volume":"43","author":"Ozkurt","year":"2011","journal-title":"Eurasian J. Med."},{"key":"10.1016\/j.antiviral.2016.06.011_bib69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2005.05.003","article-title":"Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy","volume":"52","author":"Ozkurt","year":"2006","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.antiviral.2016.06.011_bib70","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.ijid.2011.06.005","article-title":"Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions","volume":"16","author":"Ozturk","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2009.10.015","article-title":"Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever","volume":"47","author":"Ozturk","year":"2010","journal-title":"J.\u00a0Clin. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2016.06.011_bib72","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00261-015-0581-y","article-title":"The evaluation of abdominal findings in Crimean-Congo hemorrhagic fever","volume":"41","author":"\u00d6zmen","year":"2016","journal-title":"Abdom. Radiol. (NY)"},{"issue":"1","key":"10.1016\/j.antiviral.2016.06.011_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jmv.24312","article-title":"Cytokines as biomarkers of Crimean-Congo hemorrhagic fever","volume":"88","author":"Papa","year":"2016","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib74","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcv.2006.04.007","article-title":"Cytokine levels in Crimean-Congo hemorrhagic fever","volume":"36","author":"Papa","year":"2006","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib75","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/CVI.00530-09","article-title":"Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever","volume":"17","author":"Saksida","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib76","doi-asserted-by":"crossref","DOI":"10.7883\/yoken.JJID.2015.533","article-title":"The first fatal case of Crimean-Congo Hemorrhagic Fever due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus","author":"Salehi-Vaziri","year":"2016","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.17305\/bjbms.2013.2408","article-title":"Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever","volume":"13","author":"Sari","year":"2013","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"10","key":"10.1016\/j.antiviral.2016.06.011_bib78","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-10-207","article-title":"Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis","volume":"2010","author":"Soares-Weiser","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib79","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jinf.2007.02.010","article-title":"Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever","volume":"55","author":"Sonmez","year":"2007","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.antiviral.2016.06.011_bib80","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jinf.2015.07.003","article-title":"Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey","volume":"71","author":"Sunbul","year":"2015","journal-title":"J.\u00a0Infect."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.antiviral.2016.06.011_bib81","doi-asserted-by":"crossref","first-page":"S794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","article-title":"The clinical pathology of Crimean-Congo hemorrhagic fever","volume":"11","author":"Swanepoel","year":"1989","journal-title":"Rev. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2016.06.011_bib82","first-page":"10","article-title":"Ratio of neutrophil to lymphocyte counts in crimean Congo hemorrhagic fever","volume":"7","author":"Turkdogan","year":"2016","journal-title":"J.\u00a0Clin. Anal. Med."},{"key":"10.1016\/j.antiviral.2016.06.011_bib83","doi-asserted-by":"crossref","first-page":"e616","DOI":"10.1016\/j.ijid.2012.04.009","article-title":"C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever","volume":"16","author":"Turkdogan","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib84","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/QCO.0b013e3282a56a0a","article-title":"Crimean-Congo hemorrhagic fever","volume":"20","author":"Vorou","year":"2007","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib85","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cytogfr.2008.11.001","article-title":"Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis","volume":"19","author":"Weber","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.antiviral.2016.06.011_bib86","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3201\/eid1307.070068","article-title":"Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients","volume":"13","author":"W\u00f6lfel","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib87","first-page":"742","article-title":"The early prediction of fatality in Crimean Congo hemorrhagic fever patients","volume":"32","author":"Yesilyurt","year":"2011","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.antiviral.2016.06.011_bib88","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jmv.24021","article-title":"Importance of serum adipokine and ghrelin levels in patients with Crimean-Congo hemorrhagic fever","volume":"87","author":"Yilmaz","year":"2015","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib89","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jcv.2010.11.014","article-title":"The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever","volume":"50","author":"Yilmaz","year":"2011","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib90","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcv.2010.01.010","article-title":"The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria","volume":"47","author":"Yilmaz","year":"2010","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib91","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijid.2008.07.021","article-title":"The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007","volume":"13","author":"Yilmaz","year":"2009","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.24454","article-title":"The prognostic significance of serum troponin T levels in Crimean-Congo Hemorrhagic Fever patients","author":"Yilmaz","year":"2015","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0972-9062.154141","article-title":"Effect of tumour necrosis factor-alpha and interleukin-6 promoter polymorphisms on course of Crimean-Congo hemorrhagic fever in Turkish patients","volume":"52","author":"Yilmaz","year":"2015","journal-title":"J.\u00a0Vector Borne Dis."},{"key":"10.1016\/j.antiviral.2016.06.011_bib94","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jcv.2008.03.003","article-title":"Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever","volume":"42","author":"Yilmaz","year":"2008","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.06.011_bib95","first-page":"150","article-title":"Does electrocardiography at admission predict outcome in Crimean -Congo hemorrhagic fever?","volume":"48","author":"Yilmaz","year":"2011","journal-title":"J.\u00a0Vector Borne Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T01:53:33Z","timestamp":1718675613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216301449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":95,"alternative-id":["S0166354216301449"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}